5月4日 -
** 威廉·布莱尔（William Blair）首次覆盖人工智能诊断公司Heartflow HTFL.O，给予“跑赢大盘”评级，并指出其基于人工智能的无创心脏诊断平台具有增长潜力
** 该券商表示，该平台无需侵入性检查即可提供可操作的临床信息，有助于指导冠状动脉疾病的诊断与管理
** 指出该技术拥有丰富的临床数据支撑，并补充称HTFL已着手开展临床试验，旨在通过无症状筛查这一预计价值60亿美元的市场机会，将总可寻址市场规模扩大一倍以上
** 指出其采用类似软件的商业模式，采用按使用付费的结构且毛利率超过80%，可在增量成本有限的情况下实现规模化
** 截至上一交易日收盘，HTFL年内累计下跌1.7%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.